Atara Biotherapeutics

ATRANasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$80.703 M

$8.04 -3.94%

Close of 6 Nov 2026

As of 6 Nov 2026, Atara Biotherapeutics (ATRA) has a market capitalization of $80.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$120.8M

#2431 by revenue

Earnings

$32.7M

#1709 by earnings

Shares outstanding

10,037,710

Latest filing cover page

P/E ratio

2.5

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#114LENZ TherapeuticsLENZ$95.4M
#115Neumora TherapeuticsNMRA$92.4M
#116Atara BiotherapeuticsATRA$80.7M
#117OKYO PharmaOKYO$73.5M
#118Tenaya TherapeuticsTNYA$72.6M

What if Atara Biotherapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,813,079

Per share 349,885× higher

Bitcoin $1.53T

$152,210.82

Per share 18,932× higher

Apple $5.02T

$499,693.92

Per share 62,151× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Atara Biotherapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.